These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2805602)

  • 21. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
    Filep JG; Hermán F; Földes-Filep E; Schneider F; Braquet P
    Br J Pharmacol; 1992 Apr; 105(4):912-8. PubMed ID: 1324056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous platelet activating factor does not modulate blood flow and metabolism in normal rat brain.
    Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM
    Stroke; 1990 Mar; 21(3):459-62. PubMed ID: 2309270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interference of WEB 2086 and BN 52021 with Paf-induced effects on guinea-pig trachea.
    Brunelleschi S; Renzi D; Ledda F; Giotti A; Fantozzi R; Brink C; Benveniste J
    Br J Pharmacol; 1989 Jun; 97(2):469-74. PubMed ID: 2758225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin.
    Dixon EJ; Wilsoncroft P; Robertson DN; Page CP
    Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
    Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G
    Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet-activating factor causes pulmonary vasodilation in the rat.
    McMurtry IF; Morris KG
    Am Rev Respir Dis; 1986 Oct; 134(4):757-62. PubMed ID: 3094417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.
    Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P
    J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
    Imai T; Vercellotti GM; Moldow CF; Jacob HS; Weir EK
    J Lab Clin Med; 1988 Feb; 111(2):211-7. PubMed ID: 3339274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of PAF in the allergic pleurisy caused by ovalbumin in actively sensitized rats.
    Martins MA; Castro Faria Neto HC; Bozza PT; e Silva PM; Lima MC; Cordeiro RS; Vargaftig BB
    J Leukoc Biol; 1993 Jan; 53(1):104-11. PubMed ID: 8381149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relevance of eicosanoids including PAF for the biochemical regulation of cardiac rhythm.
    Mest HJ; Riedel A; Meyer E; Hoffmann IH; Mentz G; Mentz P; Tschorn W; Sperling J
    Prog Clin Biol Res; 1989; 301():475-9. PubMed ID: 2798457
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of PAF antagonists on cerulein-induced pancreatitis.
    Jancar S; Abdo EE; Sampietre SN; Kwasniewski FH; Coelho AM; Bonizzia A; Machado MC
    J Lipid Mediat Cell Signal; 1995 Jan; 11(1):41-9. PubMed ID: 7537159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats.
    Zhou W; Chao W; Levine BA; Olson MS
    Am J Physiol; 1992 Nov; 263(5 Pt 1):G587-92. PubMed ID: 1443133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.
    Filep J; Hermán F; Braquet P
    Lipids; 1991 Dec; 26(12):1356-8. PubMed ID: 1819733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of specific platelet-activating factor binding sites in the rat retina.
    Thierry A; Doly M; Braquet P; Cluzel J; Meyniel G
    Eur J Pharmacol; 1989 Apr; 163(1):97-101. PubMed ID: 2545464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
    Teather LA; Magnusson JE; Wurtman RJ
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of PAF antagonists on renal vascular escape and tachyphylaxis in perfused rabbit kidney.
    Ferreira MG; Braquet P; Fonteles MC
    Lipids; 1991 Dec; 26(12):1329-32. PubMed ID: 1819726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ro 19-3704 directly inhibits immunoglobulin E-dependent mediator release by a mechanism independent of its platelet-activating factor antagonist properties.
    Gilfillan AM; Wiggan GA; Hope WC; Patel BJ; Welton AF
    Eur J Pharmacol; 1990 Feb; 176(3):255-62. PubMed ID: 1691711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    Braz J Med Biol Res; 1987; 20(5):595-7. PubMed ID: 3452452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.